fig1
![Promises and pitfalls of targeted agents in chronic lymphocytic leukemia](https://image.oaes.cc/4d2d9912-8197-4ac7-98f6-2a27da669b38/3472.fig.1.jpg)
Figure 1. Target agents in chronic lymphocytic leukemia. AKT: v-akt murine thymoma viral oncogene; PI3K: phosphatidylinositol 3-kinase; SYK: spleen tyrosine kinase; BTK: bruton tyrosine kinase; BCR: B-cell receptor; BCL2: B-cell lymphoma 2; CLL: chronic lymphocytic leukemia; BAK: BCL2 homologous antagonist killer; BAX: BCL2 associated X; BH3: BCL2 homology domain 3